Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

GM3 ganglioside

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving GM3 ganglioside

Every recorded step where this molecule takes part

All 1 Consumed 0 Produced 1

Showing all 1 reactions.

Recent literature

Refresh

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Pathophysiological mechanisms of organ injury in Fabry disease: Update via multi-omics.

    Wei Z, Yang J, Han Z, Zhang X, Wang B. · 2025-11-25

    open access unreviewed
  2. 2
    Ceramides and Type 2 Diabetes: A Scoping Review of Mechanisms, Insulin Resistance, and Nutritional Interventions.

    Collins K, Chawla J, Krishnakumar P. · 2026-05-11

    open access unreviewed
  3. 3
    A review of recent advances in exosome-mediated drug delivery for regenerative therapy and immunomodulation.

    Azhar MA, Alshehri E, Assiri AM, Broering DC, Yaqinuddin A, Mir TA. · 2026-05-04

    open access unreviewed
  4. 4
    Cryptic DNA sequences encode a temperature sensor to regulate mitochondrial suicide during neuronal differentiation.

    Vujovic F, Simonian M, Quek LE, Peng KY, Hunter N, Farahani RM. · 2026-05-02

    open access unreviewed
  5. 5
    Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism.

    Zhou J, Zhuang H, Sheng Q, Qiu Z, Chen Y. · 2026-04-29

    open access unreviewed
  6. 6
    Listening to Cellular Whispers through Glycosphingolipids: A Comprehensive Review of Recent Advancements in Glycosphingolipid Analysis and Annotation.

    Beirami AD, Rampler E. · 2026-04-17

    open access unreviewed
  7. 7
    Lipidomic analyses of large cohort studies define the role of lipid metabolism in bridging diet and cardio-metabolic health.

    Beyene HB, Wang T, Cinel M, Mellett NA, Duong T, Buuren-Milne MV, Faulkner AN, Wu J, Olshansky G, Shaw JE, Ma… · 2026-03-30

    open access unreviewed
  8. 8
    Deciphering the role of glycolipids as emerging therapeutic targets in EMT-driven cancer progression.

    Mukherjee A, Paul S, Datta C, Bhattacharjee A. · 2026-03-20

    open access unreviewed
  9. 9
    B4Galnt1 Deficiency Reverses Severe Neurological Symptoms in a Mouse Model of Tay-Sachs Disease.

    Yanbul S, Calıskan TU, Turali MC, Seyrantepe V. · 2026-03-09

    open access unreviewed
  10. 10
    Writers and readers of sialylation in immunoregulation in cancer.

    Decloquement M, Macauley MS. · 2026-02-04

    cited 1× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.